Neurocrine Biosciences, Inc. (NBIX)
155.92
-0.67
(-0.43%)
USD |
NASDAQ |
Aug 27, 16:00
155.88
-0.04
(-0.03%)
After-Hours: 20:00
Neurocrine Biosciences Total Return Level : 155.92 for Aug. 27, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 27, 2026 | 155.92 |
| August 26, 2026 | 156.59 |
| August 25, 2026 | 153.37 |
| August 24, 2026 | 153.04 |
| August 21, 2026 | 152.57 |
| August 20, 2026 | 152.93 |
| August 19, 2026 | 155.54 |
| August 18, 2026 | 154.23 |
| August 17, 2026 | 154.49 |
| August 14, 2026 | 152.72 |
| August 13, 2026 | 150.82 |
| August 12, 2026 | 156.49 |
| August 11, 2026 | 161.94 |
| August 10, 2026 | 164.92 |
| August 07, 2026 | 163.41 |
| August 06, 2026 | 159.82 |
| August 05, 2026 | 161.50 |
| August 04, 2026 | 166.06 |
| August 03, 2026 | 166.23 |
| July 31, 2026 | 166.80 |
| July 30, 2026 | 185.50 |
| July 29, 2026 | 180.79 |
| July 28, 2026 | 182.83 |
| July 27, 2026 | 176.41 |
| July 24, 2026 | 175.77 |
| Date | Value |
|---|---|
| July 23, 2026 | 174.15 |
| July 22, 2026 | 172.69 |
| July 21, 2026 | 179.05 |
| July 20, 2026 | 173.00 |
| July 17, 2026 | 170.88 |
| July 16, 2026 | 171.55 |
| July 15, 2026 | 172.05 |
| July 14, 2026 | 172.04 |
| July 13, 2026 | 174.10 |
| July 10, 2026 | 177.11 |
| July 09, 2026 | 180.55 |
| July 08, 2026 | 178.24 |
| July 07, 2026 | 177.49 |
| July 06, 2026 | 174.10 |
| July 02, 2026 | 174.26 |
| July 01, 2026 | 167.77 |
| June 30, 2026 | 168.54 |
| June 29, 2026 | 170.00 |
| June 26, 2026 | 168.52 |
| June 25, 2026 | 164.18 |
| June 24, 2026 | 166.06 |
| June 23, 2026 | 161.44 |
| June 22, 2026 | 161.62 |
| June 18, 2026 | 158.29 |
| June 17, 2026 | 159.00 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Amarin Corp. Plc | 14.07 |
| Liquidia Corp. | 69.94 |
| Incyte Corp. | 127.74 |
| Krystal Biotech, Inc. | 357.46 |
| Halozyme Therapeutics, Inc. | 106.92 |